![]() |
|
|
MB Hargreaves, BC Jones, DA Smith and A Gescher
Medical Research Council Toxicology Unit, University of Leicester, UK.
The cytochrome P450 isoenzyme P4502E1 is constitutively expressed in human liver and catalyzes the oxidation of many known or suspected carcinogens of low molecular weight. In this structure-metabolism study, the role that heteroatoms in heterocyclic compounds play in determining their affinity for P4502E1 was investigated. The ability of 16 six-membered and 10 five-membered compounds to inhibit the hydroxylation of p-nitrophenol, which is specifically catalyzed by P4502E1, was studied in suspensions of microsomes from rat livers in which P4502E1 had been induced by inclusion of acetone in the drinking water. Apparent Ki values were extrapolated from kinetic models of Dixon or Cornish-Bowden plots for enzyme inhibition. Enzyme inhibition was generally of the non-or uncompetitive type. Pyridine was the most potent and benzene one of the least potent inhibitors, with Ki values of 0.4 microM and 8,400 microM, respectively. Pyridazine was less inhibitory than 1,3,5-triazine, which inhibited P4502E1 to a lesser degree than pyrazine and pyrimidine. Among the unsubstituted unsaturated five-membered ring molecules, pyrrole was a better inhibitor than furan or thiophene. 4-Methylimidazole was a much stronger inhibitor than imidazole or 1-and 2-methylimidazole. The ability of compounds to inhibit P4502E1 seems to depend in the main on the presence of a nitrogen atom in the molecule and on the ability of the nitrogen lone pair of electrons to ligand to the heme.
This article has been cited by other articles:
![]() |
S. L. Collom, R. M. Laddusaw, A. M. Burch, P. Kuzmic, M. D. Perry Jr., and G. P. Miller CYP2E1 Substrate Inhibition: MECHANISTIC INTERPRETATION THROUGH AN EFFECTOR SITE FOR MONOCYCLIC COMPOUNDS J. Biol. Chem., February 8, 2008; 283(6): 3487 - 3496. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Wang, M. Neuvonen, X. Wen, J. T. Backman, and P. J. Neuvonen Gemfibrozil Inhibits CYP2C8-Mediated Cerivastatin Metabolism in Human Liver Microsomes Drug Metab. Dispos., December 1, 2002; 30(12): 1352 - 1356. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-S. Wang, J. T. Backman, P. Taavitsainen, P. J. Neuvonen, and K. T. Kivistö Involvement of CYP1A2 and CYP3A4 in Lidocaine N-Deethylation and 3-Hydroxylation in Humans Drug Metab. Dispos., August 1, 2000; 28(8): 959 - 965. [Abstract] [Full Text] |
||||